NEW YORK, July 10, 2017 /PRNewswire/ --
If you want a Stock Review on CERN, VEEV, RCM or RNVA then come over to http://dailystocktracker.com/register/and sign up for your free customized report today. On Friday, July 07, 2017, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged higher at the closing bell. Eight out of nine sectors ended last
North Kansas City, Missouri headquartered Cerner Corp.'s stock climbed 1.09%, finishing last Friday's trading session at $65.74. A total volume of 2.00 million shares was traded. The Company's shares have gained 10.51% over the previous three months and 38.78% since the start of this year. The stock is trading above its 50-day and 200-day moving averages by 0.30% and 14.55%, respectively. Additionally, shares of Cerner, which designs, develops, markets, installs, hosts, and supports health care information technology, health care devices, hardware, and content solutions for health care organizations and consumers in the US and internationally, have a Relative Strength Index (RSI) of 46.99. See our free and comprehensive research report on CERN at:
Shares in Pleasanton, California headquartered Veeva Systems Inc. ended at $62.35, rising 3.37% from the last trading session. The stock recorded a trading volume of 1.17 million shares. The Company's shares have surged 21.73% over the previous three months and 53.19% since the start of this year. The stock is trading 3.97% and 30.59% above its 50-day and 200-day moving averages, respectively. Moreover, shares of Veeva Systems, which provides cloud-based software for the life sciences industry in North America, Europe, Asia/Pacific, and internationally, have an RSI of 54.71. VEEV free research report PDF is just a click away at:
On Friday, shares in R1 RCM Inc. recorded a trading volume of 334,705 shares. The stock declined 0.27%, closing the day at $3.68. The Company's shares have gained 14.64% over the previous three months and 63.56% on an YTD basis. The stock is trading 31.09% above its 200-day moving average. Additionally, shares of R1 RCM, which helps healthcare providers generate sustainable improvements in their operating margins and cash flows, while also enhancing patient, physician and staff satisfaction for customers, have an RSI of 46.83. Sign up for your complimentary report on RCM at:
At the close of trading on Friday, shares in West Palm Beach, Florida headquartered Rennova Health Inc. recorded a trading volume of 823,940 shares. The stock finished the session 0.69% lower at $0.35. The Company's shares are trading below their 50-day moving average by 35.12%. Furthermore, shares of Rennova Health, which provides diagnostics and supportive software solutions to healthcare providers, have an RSI of 34.96. Register for free on DailyStockTracker.com and download the latest research report on RNVA at:
Daily Stock Tracker:
Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
DST has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: email@example.com Phone number: (207)331-3313 Office Address: 377 Rivonia Boulevard, Rivonia, South Africa
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA
Subscribe to our Free Newsletters!
Vitrectomy is a surgical procedure performed to remove a part or whole of the vitreous humor ...
Boosting metabolism is what you might need to pump your weight loss regime. Slow body metabolism ...
Telemedicine is a rapidly growing field aimed at providing health and clinical services remotely ...View All